echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > CSH Innovation Forum| Han Yue, Xu Yajing, Wang Yu, Zhao Mingfeng, Yi Hongmei invite you to join the academic feast on September 23-25 - the 17th National Hematology Academic Conference of the Chinese Medical Association

    CSH Innovation Forum| Han Yue, Xu Yajing, Wang Yu, Zhao Mingfeng, Yi Hongmei invite you to join the academic feast on September 23-25 - the 17th National Hematology Academic Conference of the Chinese Medical Association

    • Last Update: 2022-10-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Listening to the sound of blood and perceiving the rhythm of life, the much-anticipated "17th National Hematology Academic Conference of the Chinese Medical Association" will be grandly opened
    on September 23-25, 2022 at the National Convention and Exhibition Center in Shanghai.
    The conference was hosted by the Chinese Medical Association and the Hematology Branch of the Chinese Medical Association, hosted by the Shanghai Medical Association, co-organized by Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the First Affiliated Hospital of Soochow University, and the Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, with the theme of "respect, inheritance, collaboration and innovation", specially invited famous experts at home and abroad to talk about the latest progress
    in the field of blood diseases.



    BEST AVAILABLE TREATMENT Forum

    September 23, 8:30-11:30


    Professor Han Yue

    The First Affiliated Hospital of Soochow University


    It is a great honor to receive an invitation from the Hematology Branch of the Chinese Medical Association to co-host the 17th Academic Conference of Hematology of the Chinese Medical Association - BEST AVAILABLE TREATMENT Forum
    .
    Professor Peng Jun of Qilu Hospital of Shandong University, Professor Li Jianyong of the First Affiliated Hospital of Nanjing Medical University, Professor Xu Kailin of the Affiliated Hospital of Xuzhou Medical University, Professor Hu Jianda of Union Hospital Affiliated to Fujian Medical University, Professor Liu Qiqi of Southern Hospital of Southern Medical University, and Professor Xiao Zhijian of Hematology Hospital of Institute of Hematology of Chinese Academy of Medical Sciences were invited to bring wonderful academic lectures
    。 At the same time, Professor Han Weidong of the 301 Hospital of the General Hospital of the People's Liberation Army of Chinese, Professor Li Yangqiu, Director of the Institute of Hematology of Jinan University, Professor Li Juan of the First Affiliated Hospital of Sun Yat-sen University, Professor Mei Heng of the Union Hospital Affiliated to Tongji College of Huazhong University of Science and Technology, Professor Zhu Qi of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and many other hematology experts were invited to conduct a special discussion
    .
    The conference brings together major research achievements in the field of hematology, and combines relevant guidelines at home and abroad to find innovative clinical breakthrough points, providing clinicians with a platform for mutual communication and academic progress, and jointly building a new environment
    for innovation and development.
    I wish this conference a complete success!


    Porting Frontier Forums

    September 23, 8:30-12:00


    Professor Xu Yajing

    Xiangya Hospital, Central South University


    In recent years, with the continuous maturity of hematopoietic stem cell transplantation technology, the continuous expansion of transplant diseases, the continuous breakthrough of transplant patients, and the rapid growth
    of hematopoietic stem cell transplantation cases at home and abroad.
    The GVHD-free survival rate (GRFS) of transplant patients and the improvement of quality of life are receiving increasing attention
    .
    The Transplantation Frontier Forum sub-venue invited top experts at home and abroad to give wonderful lectures
    on the new progress of chronic GVHD pathogenesis, the experience of hematopoietic stem cell transplantation treatment for rare diseases, the protection of fertility function after hematopoietic stem cell transplantation, and the hematopoietic stem cell transplantation of genetic metabolic diseases 。 Another highlight of this sub-venue is the interview on China's transplant prospective clinical research co-chaired by Professor Zhang Xiaohui of Peking University People's Hospital and Professor Xia Linghui of Union Hospital Affiliated to Huazhong University of Science and Technology, and experts such as Professor Xuan Li from Guangzhou Southern Hospital, Professor Jiang Erlie from the Institute of Hematology of Chinese Medical Academy, and Professor Chen Ting from Xinqiao Hospital of Army Military Medical University will present their latest clinical research results
    .
    Stay tuned!


    Clinical Research Session

    September 23, 8:30-11:30


    Professor Wang Yu

    Peking University People's Hospital


    Welcome to the Clinical Research Session, which is designed specifically for clinical research institutes
    .
    Two methodologists and four physicians with rich clinical research experience were invited to share the
    conference.
    The content of the sharing is divided into six sections, evidence-based clinical guidelines GRADE methodology, classification design of clinical research, innovative thinking and topic selection, registration and management implementation of clinical research, and finally data analysis
    .
    The content is detailed and practical, and we invite you to participate together!


    Innovative Cell Therapy Forum

    September 9, 23:8-30:11


    Professor Zhao Mingfeng

    Tianjin First Central Hospital


    In recent years, cellular immunotherapy represented by CAR-T has made breakthroughs in blood diseases, especially in the treatment of acute lymphoblastic leukemia, lymphoma, multiple myeloma, etc.
    , and is a milestone event
    in the treatment of hematological tumors.
    At present, cell therapy is developing rapidly, especially China's cell therapy level has been at the forefront of
    the world.
    This forum highlights the innovation of cell therapy, invites top experts at home and abroad in the field to introduce the latest research results, and will discuss the latest CAR-T therapeutic targets of acute myeloid leukemia, the construction and application of four generations of CAR-T, the exploratory research of general-purpose CAR-T, the transformation application of CAR-NK and the transformation of cell therapy
    .
    Let's gather in Shanghai and share the academic feast!


    Hematology Forum

    September 9, 23:8-30:11


    Professor Yi Hongmei

    Ruijin Hospital, Shanghai Jiao Tong University School of Medicine


    Pathological diagnosis is essential for the diagnosis of lymphoma, but the pathological diagnosis needs to be judged in conjunction with clinical practice
    .
    Professor Liu Weiping of West China Hospital of Sichuan University, Professor Wang Zhe of Xijing Hospital of Fourth Military Medical University, Professor Wang Zhaofu and Professor Dong Lei of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine will be invited to make special reports
    .
    We invite you to work together to create a new chapter in lymphoma diagnosis and treatment!



    September 23-25

    The 17th National Conference on Hematology of the Chinese Medical Association

    Respect, heritage, collaboration, innovation

    Welcome to Shanghai!


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.